Medically unexplained myopathy due to ipecac abuse

Psychosomatics

Volumn 47, Issue 2, 2006, Pages 167-169

  Rashid, Navid ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EMETINE; IPECAC; MIRTAZAPINE;

ABDOMINAL PAIN; ADOLESCENT; ANXIETY DISORDER; ARTICLE; CARDIOMYOPATHY; CASE REPORT; CONFLICT; DEPRESSION; DISTRESS SYNDROME; DIVORCE; DRUG ABUSE; FAMILY COUNSELING; FEMALE; HUMAN; MARRIAGE; MUSCLE WEAKNESS; MYOCARDITIS; MYOPATHY; PARENT; PSYCHOTHERAPY; QT PROLONGATION; SINUS TACHYCARDIA; SYMPTOM;

EID: 33644772817     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.47.2.167     Document Type: Letter

References (7)

1. American Academy of Pediatrics Committee on Injury, Violence, and Poison Prevention: Policy Statement: Poison Treatment in the Home. Pediatrics 2003; 112:1182-1185
2. American College of Emergency Physicians: Clinical Policy for the Initial Approach to Patients Presenting With Acute Toxic Ingestion or Dermal or Inhalation Exposure. Ann Emerg Med 1995; 25:570-585
3. Palmer EP, Guay AT: Reversible myopathy secondary to abuse of ipecac in patients with major eating disorders. N Engl J Med 1985; 313:1457-1459
4. Manno BR, Manno JE: Toxicology of ipecac: a review. Clin Toxicol 1997; 10:221-242
5. Schneider DJ, Perez A, Knilans TE: Clinical and pathological aspects of cardiomyopathy from ipecac administration in Munchausen's syndrome by proxy. Pediatrics 1996; 97:902-906
6. Mateer JE, Farrell BJ, Chou SM: Reversible ipecac myopathy. Arch Neurol 1985; 42:188-190
7. Carracio C, Blotny K, Ringel R: Sudden onset of profound weakness in a toddler. J Pediatr 1993; 122:663-667